Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Xenetic Biosciences Inc (XBIO)

Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment ACCESSWIRE - Tue Dec 17, 3:15AM CST

Reid Bissonnette, Ph.D, Executive Consultant for Translational Research and Development at Xenetic, discusses extension of its Research Agreement with the University of Virginia for the advancement of...

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform ACCESSWIRE - Mon Dec 16, 3:00AM CST

Company continuing to advance DNase-based oncology program towards clinical proof-of-concept studies in multiple indications

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program ACCESSWIRE - Thu Dec 5, 2:45AM CST

Collaboration utilizes PeriNess' expertise in clinical development of human recombinant DNase and bolsters efforts towards clinical proof-of-concept studies in multiple indications

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment ACCESSWIRE - Fri Nov 22, 3:15AM CST

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (SITC)...

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis ACCESSWIRE - Thu Nov 21, 2:30AM CST

Data presented at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer

XBIO : 4.04 (-2.65%)
Xenetic Biosciences: Q3 Earnings Snapshot AP - Tue Nov 12, 6:11PM CST

Xenetic Biosciences: Q3 Earnings Snapshot

XBIO : 4.04 (-2.65%)
Xenetic Biosciences: Q2 Earnings Snapshot AP - Tue Aug 13, 3:49PM CDT

Xenetic Biosciences: Q2 Earnings Snapshot

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Announces Executive Leadership Transition ACCESSWIRE - Wed May 22, 12:00PM CDT

Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer

XBIO : 4.04 (-2.65%)
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update ACCESSWIRE - Fri May 10, 3:30AM CDT

FRAMINGHAM, MA / ACCESSWIRE / May 10, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...

XBIO : 4.04 (-2.65%)
Xenetic Biosciences: Q1 Earnings Snapshot AP - Thu May 9, 5:56PM CDT

Xenetic Biosciences: Q1 Earnings Snapshot

XBIO : 4.04 (-2.65%)

Barchart Exclusives

Bearish on the Market? 2 Defensive Stocks for Maximum Portfolio Protection. Barchart - 1 hour ago
As economic growth is anticipated to slow, UBS highlights these two dividend-paying defensive stocks as smart picks, shifting focus away from cyclical stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot